Patients are central to everything we do – bringing people hope.
At MADP, we work to prevent disease so that fewer individuals and families ever have to hear the devastating words:
“You have cancer.”
We want every person to know that up to 90% heart disease is preventable, and to live free from the fear of a sudden heart attack – or the heartbreak of losing someone they love.
And for those who do face a diagnosis, we want them to hear something equally hopeful:
“You’re going to be okay.”
By expanding access to the life-saving benefits of precision medicine, MADP delivers hope – supporting healthier lives and more time with the people who matter most.
MADP Alliance for Disease Prevention was founded by senior leaders in precision medicine, healthcare, and the life sciences who recognized an urgent need: to close the gap between clinical advancements and patient access.
Drawing upon expertise shaped through national initiatives – including the White House Precision Medicine Initiative, the Human Genome Project, and the National Microbiome Initiative (NMI) – MADP was established as an independent public-health nonprofit committed to ensuring that the benefits of precision medicine reach all communities.
MADP operates as a collaborative alliance working with leading clinicians, institutions, and academic researchers. Our mission is not to duplicate existing systems, but to strengthen them – saving lives, accelerating innovation – and bringing hope to patients and families.
Precision Medicine for Prevention & Early Detection of NCDs
The rapid pace of discovery underscores the essential role of precision medicine and NCD prevention in shaping long-term health. By enabling smarter screening and smarter testing, we open the door to earlier detection, more effective prevention, and ultimately, improved patient outcomes.
Precision Medicine for Cancer Patients: Ensuring Access to Life-Saving Testing
Although MADP’s primary mission centers on cancer prevention and early detection, the MADP Circle of Hope was developed in direct response to requests from patients and families seeking trusted clinical resources at the time of a new cancer diagnosis.
For patients facing cancer, precision testing can guide more effective, personalized treatment. Tumor biomarker testing is often standard of care at National Cancer Institute (NCI)–designated cancer centers but may not be routinely ordered or accessible in many community or rural settings.
MADP is working to close this gap – helping ensure that all cancer patients, regardless of zip code, have access to this life-saving testing and targeted treatments.
At the Forefront of Precision Medicine
Among the new frontiers in precision medicine is the microbiome. Originally founded as Microbiome Alliance for Disease Prevention, we believe the microbiome is an important cornerstone of health. It has a role in regulating immunity, influencing chronic disease risk, affecting cancer progression, and even shaping how medications are absorbed.
Researchers at leading institutions – including Mayo Clinic, Stanford, and Memorial Sloan Kettering – continue to deepen our understanding of this vital system.
MADP stays at the forefront of microbiome-focused precision medicine by translating this emerging science into practical prevention and clinical care – helping ensure that new discoveries reach patients sooner and are responsibly integrated into everyday clinical practice.
Closing the Gap — Today, Tomorrow, and for Generations to Come
Precision medicine is redefining healthcare – yet it takes approximately fifteen years for such clinical advancements to reach everyday patient care. When battling cancer, heart disease, or Alzheimer’s – patients don’t have fifteen years to wait.
MADP is closing that gap. We translate breakthroughs into hope by connecting individuals with the knowledge and patient support resources – so that every community benefits from the promise of precision medicine – today.
We are strategic, intentional, and we push boundaries leading the path forward – today, tomorrow, and for generations to come.
Together, we can close the gap.
Together, we can end chronic disease.
COLLABORATION – Strength of the collective voice.
STRATEGY – Smart and strategic advancing public health.
INTEGRITY – Transparent and dedicated to saving lives.
ACTION – Intentional and relentless driving mission and vision.
ADVOCACY – Educate and empower millions to prevent disease.
Advancing healthcare through precision medicine and smarter preventive measures to end chronic disease ~ with the microbiome at the cornerstone.
MADP Collaborative Alliance is a convergence of strategic partners leading the path forward in precision, prevention, and early detection – TOGETHER. Our partners value the strategy of collaboration and the collective sharing of knowledge, expertise, and best practices to improving our nation’s health and the health of humanity across the globe.
MADP Clinical Cancer Alliance is a convergence of strategic partners devoted to accelerating cancer prevention, early detection, and integrative precision cancer treatments. TOGETHER we value the strategy of collaboration and the collective sharing of knowledge, expertise, and best practices to combat cancer and provide life-saving hope for those in need.
MADP is proud to showcase some of our MADP Collaborative Partners and collaborate with mission-aligned organizations committed to advancing public health. Together, we amplify our collective impact — reaching more patients, providers, and communities with critical supportive resources that promote earlier detection, smarter screening, and targeted prevention.
